Fingolimod in Treating Patients With Chemotherapy-Induced Neuropathy

Summary

This early phase I trial studies how well fingolimod works in treating patients with chemotherapy-induced nerve pain (neuropathy). Fingolimod acts by suppressing immune reactions in the brain. This study is being done to see if fingolimod can reduce neuropathy caused by chemotherapy.

Timeline

Start

2019-05-24

Primary completion

2020-12-10

Completion

2020-12-10

Drugs

Indications